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Abstract
Mitochondrial DNA (mtDNA) mutator mice are proposed to express premature aging phenotypes including kyphosis and
hair loss (alopecia) due to their carrying a nuclear-encoded mtDNA polymerase with a defective proofreading function,
which causes accelerated accumulation of random mutations in mtDNA, resulting in expression of respiration defects. On
the contrary, transmitochondrial mito-miceD carrying mtDNA with a large-scale deletion mutation (DmtDNA) also express
respiration defects, but not express premature aging phenotypes. Here, we resolved this discrepancy by generating mtDNA
mutator mice sharing the same C57BL/6J (B6J) nuclear background with that of mito-miceD. Expression patterns of
premature aging phenotypes are very close, when we compared between homozygous mtDNA mutator mice carrying a B6J
nuclear background and selected mito-miceD only carrying predominant amounts of DmtDNA, in their expression of
significant respiration defects, kyphosis, and a short lifespan, but not the alopecia. Therefore, the apparent discrepancy in
the presence and absence of premature aging phenotypes in mtDNA mutator mice and mito-miceD, respectively, is partly
the result of differences in the nuclear background of mtDNA mutator mice and of the broad range of DmtDNA proportions
of mito-miceD used in previous studies. We also provided direct evidence that mtDNA abnormalities in homozygous
mtDNA mutator mice are responsible for respiration defects by demonstrating the co-transfer of mtDNA and respiration
defects from mtDNA mutator mice into mtDNA-less (r0) mouse cells. Moreover, heterozygous mtDNA mutator mice had
a normal lifespan, but frequently developed B-cell lymphoma, suggesting that the mtDNA abnormalities in heterozygous
mutator mice are not sufficient to induce a short lifespan and aging phenotypes, but are able to contribute to the B-cell
lymphoma development during their prolonged lifespan.
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Introduction
It has been hypothesized that pathogenic mtDNA mutations
that induce significant mitochondrial respiration defects cause
mitochondrial diseases [1,2] and could also be involved in aging
and age-associated disorders including tumor development [1–5].
This hypothesis is partly supported by studies in mtDNA mutator
mice [6–8]: they possess a nuclear-encoded mtDNA polymerase
with a defective proofreading function that leads to enhanced
accumulation of random mutations in mtDNA with age, and the
subsequent phenotypic expression of age-associated respiration
defects and premature aging phenotypes, but not tumor de-
velopment.
On the contrary, our previous studies [9,10] showed that
transmitochondrial mito-miceD carrying mtDNA with a large-
scale deletion mutation (DmtDNA) expressed age-associated
respiration defects, but not express the premature aging pheno-
types. Similar results were obtained in other transmitochondrial
mito-miceCOIM, which have an mtDNA point mutation in the
COI gene [11]. Recently, we generated new transmitochondrial
mito-miceND6M, which have an mtDNA point mutation in the
ND6 gene [12] that is derived from Lewis lung carcinomas, and
confers respiration defects and overproduction of reactive oxygen
species (ROS) [13]. Mito-miceND6M did not express premature
aging phenotypes, but were prone to B-cell lymphoma de-
velopment [14]. Thus, it appears to be discrepant that premature
aging phenotypes are exclusively observed in mtDNA mutator
mice [6–8], but not in transmitochondrial mito-mice [9–11,14],
even though they all express mitochondrial respiration defects
caused by mutated mtDNA.
This discrepancy may partly be the result of differences in the
nuclear genetic background between mtDNA mutator mice and
transmitochondrial mito-mice. It is also possible that the pre-
mature aging phenotypes found exclusively in mtDNA mutator
mice are not caused by mutations in mtDNA, because inter-
mitochondrial interaction and the resultant genetic complemen-
tation in mammalian mitochondria may prevent random muta-
tions in mtDNA being expressed as respiration defects [10,15,16].
To clarify these issues, first we generated mtDNA mutator mice
with the same C57BL/6J (B6J) nuclear genetic background as that
of mito-miceD, and examined whether they still expressed
respiration defects and premature aging phenotypes. We then
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transferred mtDNA from mtDNA mutator mice into mtDNA-less
(r0) mouse cells and isolated transmitochondrial cybrids possessing
mtDNA transferred from the mtDNA mutator mice, but not
possessing defective mtDNA polymerase from the mtDNA
mutator mice, and examined whether the resultant transmito-
chondrial cybrids expressed the expected respiration defects.
Materials and Methods
Mice
Inbred B6J mice generated by sibling mating more than 40
times were obtained from CLEA Japan. Mito-miceD were
generated in our previous report [9]. Homo- and heterozygous
mtDNA mutator mice were generated based on the procedures
reported previously [6,7] with a few modifications. We converted
nucleotides 4460–4465 of the PolgA sequence from GACCGA to
GCGCGC to introduce a D257A mutation in PolgA and create
BssHII site for genotyping by PCR-RFLP method. Animal
experiments were performed in accordance with protocols
approved by the Experimental Animal Committee of the
University of Tsukuba, Japan (Approval number: 12-295).
Mouse Cell Lines and Cell Culture
Mouse B82 cells are fibrosarcomas derived from the L929
fibroblast cell line (C3H/An mouse strain) [17], and r0 B82 cells
without mtDNA were obtained in our previous study [9]. Trans-
mitochondrial cybrids were isolated by the fusion of the platelets
from mtDNA mutator mice with r0 B82 cells by polyethylene
glycol and subsequent selection that allows exclusive growth of the
trans-mitochondrial cybrids (see Table S1). For isolation of
immortalized 3T3 cells, MEFs in a 6-cm culture dish at a density
of 36105 cells per dish were cultured using the 3T3 protocol
[18,19]. Briefly, 3 days after the cells had been plated at 36105
cells per dish, we trypsinized them, counted the total cell numbers,
and then replated 36105 cells into 6-cm dishes. These processes
were repeated until immortalized cells appeared. The mouse cells
and cell lines were grown in DMEM (Sigma) containing 10% fetal
calf serum, uridine (50 ng/ml), and pyruvate (0.1 mg/ml).
Estimation of DmtDNA Proportion in Mito-Mice
The proportion of wild type mtDNA and DmtDNA was
determined by a real-time PCR technique, as described previously
[20].
Analysis of COX Activity
Histochemical analyses for COX and SDH activity were carried
out based on the procedures as described previously [21] using
cryosections (10 mm thick) of cardiac muscles and renal tissues,
and coverslips with growing 3T3 cells.
Measurement of O2 Consumption Rates in Mouse Cell
Lines
The rate of oxygen consumption was measured by trypsinizing
cells, incubating the suspension in PBS, and recording oxygen
consumption in a 2.0-ml polarographic cell at 37uC with a Clark-
type oxygen electrode (Yellow Springs Instruments).
Analysis of mtDNA Mutations
Total DNA was extracted from cells and tissues, and somatic
mtDNA mutation load was determined by PCR, cloning, and
sequencing, as described earlier (Ref.), using primers that
specifically amplified a part of COX1 gene (nucleotide pair
6,006–6,522) of mouse mtDNA. PCR products were subcloned
into the pTA2 T-vector using by TArget Clone Plus Kit
(TOYOBO, Osaka, Japan). Fifty plasmids were randomly selected
from the each sample, were isolated using DirectPrep 96 MiniPrep
Kit (Qiagen, Valencia, CA) and sequenced with M13 forward and
reverse primers using BigDye Terminator Kit (Life Technologies,
Grand Island, NY) on an Applied Biosystems 3130xl Genetic
Analyzer. Sequences were assembled and edited in GENETYX
ver10 (GENETYX Corporation, Tokyo, Japan).
Southern-blot Analysis
Total DNA (5 mg and 3 mg) extracted from cells and tissues was
digested with the restriction endonuclease XhoI. Restriction
fragments were separated in 1.0% agarose gel, transferred to
Hybond N+ membrane (GE Healthcare Lifesciences) and hybrid-
ized with alkaline phosphatase-labelled mouse mtDNA probes.
Probe-bound alkaline phosphatase was used to catalyse light
production by enzymatic decomposition of CDP-Star Detection
Reagent (GE Healthcare Lifesciences). Chemiluminescences of
fragments were measured with a bioimaging analyser, EZ-Capture
ST (ATTO).
Lactate and Glucose Measurement
To determine blood lactate and glucose concentrations, blood
was collected from the tail veins of mice. Lactate and glucose
concentrations were measured with an automatic blood lactate test
meter (Lactate Pro; Arkray) and glucose test meter (Dexter ZII;
Bayer), respectively.
Histological Analyses
Formalin-fixed, paraffin-embedded serial sections were used for
histological analyses. Hematoxylin and eosin–stained sections were
used for histopathological analysis to identify tumor tissues. The
immunohistochemical analysis was performed with antibody to
CD45 (BD Biosciences) to determine whether the tumor tissues
originated from leukocytes, and subsequently with antibodies to
B220 (BD Biosciences) and CD3 (Santa Cruz) to determine
whether the tumor tissues were of B-cell or T-cell origin,
respectively.
Measurement of ROS Production in Mitochondria
ROS generation was detected with the mitochondrial superox-
ide indicator MitoSOX-Red (Life Technologies). Cells were
incubated with 1 mM MitoSOX-Red for 15 min at 37uC in
phosphate-buffered saline (PBS), washed twice with PBS, and then
immediately analyzed with a FACScan flow cytometer (Becton
Dickinson).
Statistical Analysis
Data were analyzed by Dunnett’s test or one-way ANOVA
followed by Dunnett’s post test. Kaplan–Meier curves were
assessed with the log-rank test. Values with P,0.05 were
considered significant.
Results
Mitochondrial Respiration Defects in mtDNA Mutator
Mice with a B6J Nuclear Background
We generated heterozygous (+/m) and homozygous (m/m)
mtDNA mutator mice with a B6J nuclear background (see
Materials and Methods), and examined whether mtDNA mutator
mice with a B6J nuclear background also express respiration
defects. Young (10-month-old) mice were used for examination of
their mitochondrial respiratory function. Age-matched normal B6J
mtDNA Mutator Mice Develop Lymphomas
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mice and mito-miceD with a B6J nuclear background were used as
positive and negative controls, respectively. Histochemical analysis
of mitochondrial cytochrome c oxidase (COX) activity in mouse
tissues showed reduced COX activity in homozygous m/m
mutator mice and mito-miceD, and mild COX defects in
heterozygous +/m mutator mice (Fig. 1A).
For quantitative estimation of overall mitochondrial respiratory
function, we isolated immortalized 3T3 cell lines from mouse
embryonic fibroblasts (MEFs) by using the 3T3 protocol [18,19].
Immortalized 3T3 cell lines obtained from m/m mutator mice
(3T3m/m) and mito-miceD (3T3D) showed a similar reduction in
both COX activity (Fig. 1A) and O2 consumption rates compared
to controls (Fig. 1B). Thus, m/m mutator mice express notable
respiration defects, even when they share B6J nuclear genetic
background with that of mito-miceD.
Cotransfer of mtDNA and Respiration Defects from m/m
Mice into r0 Mouse B82 Cells
We then addressed whether respiration defects found in
mtDNA mutator mice (Fig. 1) are caused by abnormalities
accumulated in mtDNA or in nuclear DNA. It is possible that the
genetic complementation activity present in mammalian mito-
chondria [10,15,16] prevents tissues from expressing respiration
defects caused by the accumulated random mutations in mtDNA.
Moreover, considering that respiratory functions are controlled by
both mtDNA and nuclear DNA, it is still possible that
abnormalities in nuclear DNA are responsible for respiration
defects, even though mtDNA mutator mice are prone to
accumulate various somatic mutations in mtDNA [6,7,21–23].
To examine this possibility, we transferred mitochondria from
the platelets of +/m and m/m mutator mice (10 months old) into
r0 mouse B82 cells by their fusion with the platelets. Selection
medium without uridine and pyruvate excluded the unfused r0
mouse B82 cells, and allowed exclusive growth of B82mt+/m and
B82mtm/m transmitochondrial cybrids, which share the B82
nuclear background but carry mtDNA from +/m and m/m mice,
respectively (Table S1). As positive controls, we used B82mtWT
transmitochondrial cybrids, which were obtained by the fusion of
r0 mouse B82 cells with the platelets from age-matched wild-type
(WT) B6J mice (Table S1).
All isolated transmitochondrial cybrids were cultivated for 2
months to obtain a sufficient number of cells to estimate O2
consumption rates. COX activity (Fig. 2A) and O2 consumption
rates (Fig. 2B) were reduced significantly in B82mtm/m cybrids
compared to controls. These results suggest that mitochondrial
respiration defects were co-transferred with the mtDNA from m/
m mice into r0 mouse B82 cells, providing convincing evidence
that respiration defects expressed in mtDNA mutator mice are due
to mtDNA abnormalities created by the deficient proofreading
function of mtDNA polymerase. Moreover, these observations also
suggest that the transferred respiration defects were not restored
during the prolonged 2-month long cultivation of B82mtm/m
cybrids, even under conditions where the nuclear genome of the
cybrids was derived from B82 cells possessing mtDNA polymerase
with a normal proofreading function. Therefore, mtDNA abnor-
malities are furthermore transferable to following generations of
the cybrids, and would correspond to mtDNA mutations.
Sequence and Southern Blot Analyses of mtDNA from m/
m Mice
To examine whether the mtDNA abnormalities correspond to
point mutations or deletion mutations of mtDNA, we carried out
sequence analysis (Fig. 3A) and Southern blot analysis (Fig. 3B) of
mtDNA prepared from the heart of an m/m mouse (10 months
old) and B82mtm/m cybrids. The heart of an age-matched B6J
(wild-type) mouse and B82mtWT cybrids were used as controls.
Sequence analysis of fifty clones of a part of COX1 gene revealed
that significant amounts of point mutations are accumulated in
mtDNA from the heart of an m/m mutator mouse, while no
mutations were found in the heart of an age-matched B6J mouse
(Fig. 3A). Preferential accumulation of somatic point mutations in
mtDNA was also observed in B82mtm/m cybrids, when we
compared mtDNA sequence between B82mtm/m and B82mtWT
cybrids (Fig. 3A). Therefore, enhanced accumulation of the
mtDNA point mutations would partly be responsible for the
respiration defects found in tissues of m/m mutator mice (Fig. 1)
and in B82mtm/m cybrids (Fig. 2).
Southern blot analysis also showed that the heart of an m/m
mouse possessed deleted mtDNA fragments (about 8 kbp) as well
as mtDNA with normal sizes (about 16 kbp). However, B82mtm/
m cybrids did not possess detectable amounts of the deleted
mtDNA fragments (Fig. 3B). These observations suggest that the
deleted mtDNA produced in the tissues of the m/m mouse can
partly be responsible for the respiration defects (Fig. 1), but are not
able to replicate and confer respiration defects in B82mtm/m
cybrids (Fig. 2). Thus, the deleted products would correspond to
the linear mtDNA fragments newly created by the mutated
polymerase gamma of m/m mice [22], but not to mtDNA with
deletion mutations.
Lifespan and Premature Aging Phenotypes
Next, we investigated whether homozygous m/m mutator mice
carrying a B6J nuclear background also express premature aging
phenotypes. To examine this idea we started the experiments
using 6-month-old mice: 19 wild-type B6J mice, 71 mtDNA
mutator mice (39+/m and 32 m/m), and 25 mito-miceD2.0–60.8
with 2.0–60.8% DmtDNA in their tails at 4 weeks after the birth.
Median survival times of wild-type, +/m, and m/m mutator
mice were 26, 27, and 10 months, respectively (Fig. 4A), showing
that homozygous m/m mutator mice have a much shorter lifespan
than controls, even under a B6J nuclear background. Median
survival times of 10 months for our m/m mutator mice with a B6J
nuclear background is slightly shorter than the 11 months [6] and
14 months [7] of other m/m mutator mice (Table S2), probably
due to the differences in nuclear background and/or conditions for
feeding and maintenance.
When the proportions of DmtDNA in tails were restricted to
higher levels (40.0%–60.8%), 13 mito-miceD40.0–60.8 possessing
40.0%–60.8% DmtDNA in their tails had a very short lifespan (9
months; Fig. 4A) comparable to that of m/m mutator mice (10
months; Fig. 4A). Thus, damages of mtDNA would be very similar
between m/m mice and mito-miceD40.0–60.8. Moreover, all 13
mito-miceD40.0–60.8 showed kyphosis (Fig. 4B), which has been
observed in m/m mutator mice [6,7] and confirmed in this study
to be expressed in m/m mutator mice with a B6J nuclear
background (Figs. 4B and Table S2). However, alopecia, which
has been reported in m/m mutator mice as a typical premature
aging phenotype [6,7], was not observed in our m/m mutator
mice and mito-miceD40.0–60.8 sharing the same B6J nuclear
background (Fig. 4B). The absence of alopecia in both our m/m
mutator mice and mito-mceD40.0–60.8 suggest that the apparent
discrepancy in the expression of premature aging phenotypes that
were observed exclusively in mtDNA mutator mice [6,7], but not
in mito-miceD [9,10] might partly be related to slight differences in
their nuclear genetic background (Table S2).
Moreover, both the homozygous m/m mutator mice with a B6J
nuclear background and mito-mceD40.0–60.8 had low blood glucose
mtDNA Mutator Mice Develop Lymphomas
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and high blood lactate levels, while heterozygous +/m mutator
mice were normal in their levels (Fig.4C). These results are
consistent with the findings of previous studies [9,24,25] with the
exception that m/m mutator mice with a B6J nuclear background
have low blood glucose levels (Fig. 4C). These observations suggest
that homozygous m/m mutator mice have potential as a model for
the study of mitochondrial diseases as well as of aging. However,
our m/m mutator mice and mito-mceD40.0–60.8 sharing the B6J
nuclear background also showed different phenotypes associated
with diseases. For example, m/m mutator mice expressed
significant increase in the amounts of blood lactate levels
(Fig. 4C). On the contrary, mito-miceD exclusively had enlarged
kidneys with a granulated surface with renal failures [10].
Considering that mito-miceD accumulated the same DmtDNA
with age, and that m/m mutator mice accumulated mtDNA with
various somatic mutations with age, the difference of mutations in
mtDNA may partly be responsible for the difference of their
phenotypes.
Figure 1. Comparison of mitochondrial respiratory function in mtDNA mutator mice and mito-miceD. WT, wild-type mice; +/m,
heterozygous mutator mice; m/m, homozygous mutator mice; D, mito-miceD. (A) Histochemical analysis of mitochondrial respiratory enzyme
activities in the heart, kidney, and 3T3 cells. Tissue sections and 3T3 cells were stained for cytochrome c oxidase (COX) (brown) and succinate
dehydrogenase (SDH) (blue). Cells that had lost COX activity were detected as a blue colour. The proportions of DmtDNA in the heart, kidney tissues,
and 3T3 cells from mito-miceD were 82.6%, 79.1%, and 73.8%, respectively. A scale bar, 50 mm. (B) Measurement of O2 consumption rates in 3T3 cells.
Data are represented as mean values with SD (n = 3). *P,0.05 compared with wild-type mice.
doi:10.1371/journal.pone.0055789.g001
Figure 2. Cotransfer of mtDNA and respiration defects from mtDNA mutator mice into r0 mouse B82 cells. WT, wild-type mice; +/m,
heterozygous mutator mice; m/m, homozygous mutator mice. (A) Cytochemical analysis of mitochondrial respiratory enzyme activities in trans-
mitochondrial cybrids. Cells that had lost COX activity were detected as a blue colour. A scale bar, 50 mm. (B) Measurement of O2 consumption rates.
Data are represented as mean values with SD (n = 3). *P,0.05 compared with wild-type mice.
doi:10.1371/journal.pone.0055789.g002
mtDNA Mutator Mice Develop Lymphomas
PLOS ONE | www.plosone.org 5 February 2013 | Volume 8 | Issue 2 | e55789
Tumor Formation Frequencies of +/m Mice
Although heterozygous +/m mutator mice showed mild
respiration defects (Fig. 1), they had a normal lifespan (Fig. 4A)
that was comparable to a lifespan of wild-type mice. These results
are consistent with the findings of a previous study [26] that
showed that median survival times of +/m mice did not change
substantially from those of wild-type mice. However, gross
necropsy of all dead or euthanized moribund mice revealed that
15 of 29+/m mutator mice (52%) had macroscopic tumor-like
abnormalities in spleen, liver and/or lymph nodes (Table S3 and
Fig. 5A). By comparison, only 2 of 12 wild-type mice (17%) and
none of the 32 m/m mutator mice showed tumor-like abnormal-
ities (Table S3).
Histological analyses revealed that all abnormal tissues were
hematopoietic neoplasms and were positive for the pan-leukocyte
marker CD45 (Table S3 and Fig. 5B). Since there was no increase
in the number of leukemic cells in the peripheral blood of +/m
mice compared with wild-type mice (Fig. 5A), these hematological
neoplasms most likely consisted of lymphoma cells. All tumors
were of B-cell origin because they expressed the B-cell marker
B220 (Fig. 5B), and arose in the spleen, liver, lung, and/or lymph
nodes (Table S3 and Fig. 5A). These data indicated that compared
to wild-type mice, the +/m mutator mice were more prone to B-
cell lymphoma development.
The median survival times of +/m mutator mice with and
without B-cell lymphoma were 26 and 28 months, respectively
(Fig. 5C). The shorter lifespan of +/m mutator mice with B-cell
lymphoma compared with that of +/m mutator mice without B-
cell lymphoma is most likely partly the result of B-cell lymphoma
development.
Estimation of ROS in Bone Marrows of +/m Mice with and
without B-cell Lymphomas
Our previous report showed that aged mito-miceND6M
carrying an mtDNA point mutation G13997A in the ND6 gene
frequently developed B cell-lymphomas [14]. Because bone
marrow cells of mito-miceND6M overproduce ROS [14], the
overproduction of ROS in bone marrow cells of +/m mutator
mice might be crucial for the development of B-cell lymphoma
(Table S3). To examine this idea, we compared the amount of
mitochondrial ROS in the bone marrow cells of wild-type mice
with that of +/m mutator mice (20–25 months old). An increase in
the amount of mitochondrial ROS was observed only in +/m
mutator mice with B-cell lymphomas (Fig. 6). It is therefore likely
that the overproduction of ROS in bone marrow cells of +/m
mutator mice plays an important part in the formation of B-cell
lymphoma.
Discussion
By generating mtDNA mutator mice with the same B6J nuclear
background as that of mito-miceD, we can provide an answer to
the question of why premature aging phenotypes are exclusively
observed in homozygous m/m mutator mice but not in
transmitochondrial mito- miceD, even though they both express
significant respiration defects. We showed that the significant
respiration defects and high frequency of mtDNA mutations were
expressed in m/m mutator mice generated here, and can be
transferred together with the transfer of mtDNA from the platelets
of the m/m mutator mice into r0 B82 cells (Figs. 1, 2, 3). Thus,
our mutator mice also express respiration defects, even under a B6J
nuclear background, and respiration defects found in mutator
mice are caused by abnormalities in their mtDNA. However, the
m/m mutator mice with a B6J nuclear background did not express
the premature aging phenotypes of graying and alopecia, while
they did express kyphosis and had a short lifespan (Fig. 4). Similar
phenotypes were observed in mito-miceD40.0–60.8, when the
proportions of DmtDNA were restricted to higher levels (Fig. 4).
Therefore, the expression patterns of premature aging phenotypes
of m/m mutator mice with a B6J nuclear background are very
similar to that of mito-miceD carrying predominant amounts of
DmtDNA in that they both express kyphosis and have a short
lifespan, but do not express graying and alopecia. These
observations suggest that the apparent discrepancy in the presence
and absence of premature aging phenotypes in mutator mice and
mito-mice from previous studies is partly the result of differences in
their nuclear genetic background.
Heterozygous +/m mutator mice showed only slight respiration
defects (Figs. 1 and 2) and had a normal lifespan comparable to
that of wild-type mice (Fig. 4A), which are findings consistent with
a previous publication [26]. However, this study provided the new
evidence that +/m mutator mice with a B6J nuclear background
frequently develop age-associated B-cell lymphomas. The +/m
Figure 3. Sequence and Southern blot analyses of mtDNA from
mtDNA mutator mice. Total DNA was prepared from the hearts of
a 10-month-old wild-type mouse (WT) and an age matched homozy-
gous mutator mouse (m/m), and from the trans-mitochondrial cybrids
carrying mtDNA from platelets of a 10-month-old wild-type mouse and
age-matched m/m mutator mouse, respectively. (A) Sequence analysis
of 517 bp-fragments of the COX1 gene. Numbers of somatic mutations
in mtDNA of the hearts from a wild-type mouse and an m/m mouse,
and of the cybrids with mtDNA of a wild-type and an m/m mouse were
counted. (B) Southern blot analysis of XhoI-digested mtDNA. Lanes 1
and 2 represent the hearts of a WT and an m/m mouse, respectively.
Lanes 3 and 4 represent the cybrids with mtDNA of a wild-type and an
m/m mouse, respectively.
doi:10.1371/journal.pone.0055789.g003
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mutator mice developed no tumors other than B-cell lymphomas
(Table S3), despite the presence of mtDNA abnormalities in all the
tissues. Considering that 17% of the wild-type mice formed B-cell
lymphoma but no other tumors (Table S3), one answer to this
tissue-specific tumor development in +/m mice is that the nuclear
background of the B6J mice used in this study made them prone to
the development of B-cell lymphomas. In support of this notion, it
has been reported that the nuclear genetic background affects the
spectrum of tumors that develop in mice [27–30].
With respect to the mechanism underlying the development of
B-cell lymphoma in +/m mice, the overproduction of ROS in
bone marrow cells may be related, because oxidative stress induces
various types of cellular damages that can lead to genetic
instability and subsequent tumor development [31]. However, it
has been reported that tissues and cells from mtDNA mutator
mice do not overproduce ROS [7,8,32]. Our study also showed
that bone marrow cells in +/m mice do not overproduce
mitochondrial ROS (Fig. 6). In contrast, bone marrow cells from
+/m mice carrying B-cell lymphomas exclusively overproduced
mitochondrial ROS (Fig. 6). It is therefore possible that
a population of bone marrow cells was induced to overproduce
ROS as the results of B-cell lymphoma development. It is also
possible that a small population of bone marrow cells accumulates
specific mtDNA abnormalities that, by chance, induce ROS
overproduction resulting in the development of B-cell lymphoma.
The latter idea is supported by our recent findings that B-cell
lymphomas developed preferentially in transmitochondrial mito-
miceND6M carrying a ROS-inducing mtDNA mutation [14] but
not in transmitochondrial mito-miceCOIM carrying an mtDNA
point mutation that does not induce ROS overproduction [14].
Taken together, these observations suggest that mtDNA abnor-
Figure 4. Comparison of the phenotypes observed in mtDNA mutator mice and mito-miceD. (A) Kaplan–Meier survival curves of mtDNA
mutator mice and mito-miceD. Median survival times of wild-type (WT) mice (n = 19), +/m mice (n = 39), m/m mice (n = 32), mito-miceD2.0–40.0 (n = 12),
and mito-miceD40.0–60.8 (n = 13) were 26, 27, 10, 17, and 9 months, respectively. (B) WT mouse, m/m mouse, and mito-mouseD at 9 months of age.
Kyphosis was observed in homozygous m/m mutator mice and mito-miceD, while hair graying and hair loss (alopecia) were not observed. (C)
Estimation of blood glucose and blood lactate levels in mutator mice and mito-miceD40–60.8 at 9 months of age. WT, wild-type mice; +/m,
heterozygous mutator mice; m/m, homozygous mutator mice; D, mito-miceD. Data are represented as mean values with SD (n = 3). *P,0.05
compared with wild-type mice.
doi:10.1371/journal.pone.0055789.g004
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malities in +/m mice do not accelerate aging (Fig. 4A), but
preferentially induce B-cell lymphoma development (Table S3).
Because our previous studies [10,15,16] demonstrated the
presence of inter-mitochondrial interactions and the resultant
genetic complementation that occurs in mammalian mitochon-
dria, it is possible that accumulated random mutations in mtDNA
complemented each other and fail to induce the respiration defects
found in mtDNA mutator mice. However, this study provided
convincing evidence that respiration defects can be transferred
together with mtDNA from mtDNA mutator mice into r0 mouse
Figure 5. B-cell lymphoma formation in the tissues of aged +/m mutator mice. WT, wild-type mice; +/m, heterozygous mutator mice. (A)
Gross necropsy of euthanized moribund mice (upper panels), tissues (middle panels), and smear samples of peripheral blood stained with Giemsa
(lower panels). Left and right panels represent a euthanized moribund wild-type (WT) mouse without tumors and a euthanized moribund +/m mouse
with tumors (+/m mouse-4; see Table S2), respectively. Giemsa-stained preparations show the absence of leukemic cells in the peripheral blood of
both wild-type and +/m mice. Sp, spleen; Li, liver; LN, lymph node; PB, peripheral blood. Scale bars represent 1 cm (middle panels) and 50 mm (lower
panels). (B) Histological analyses of serial sections of the liver to identify B-cell lymphoma. Hematoxylin and eosin (HE) staining to show tumor
formation; CD45, immunohistochemistry using antibody to CD45 to detect leukocytes; B220, immunohistochemistry using antibody to B220 to
detect B cells; CD3, immunohistochemistry using antibody to CD3 to detect T cells. The tissues of WT mice have a normal structure (left), whereas
those of +/m mice show of the development of B-cell lymphoma, because they stained positively with CD45 and B220, but not with CD3 (right). A
scale bar, 50 mm. (C) Kaplan–Meier survival curves of +/m mice with or without lymphoma. Median survival times of +/m mice with lymphoma (n = 15)
and +/m mice without lymphoma (n= 14) were 26 and 28 months, respectively. +, +/m mice with lymphoma; 2, +/m mice without lymphoma;
P= 0.362.
doi:10.1371/journal.pone.0055789.g005
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B82 cells (Fig. 2). These findings suggest that respiration defects in
mtDNA mutator mice (Fig. 1) are caused by abnormalities in their
mtDNA. One explanation of why random mutations in the
mtDNA of mtDNA mutator mice induce respiration defects in the
presence of mitochondrial genetic complementation is that the
extremely high frequency of somatic mutations in mtDNA causes
instability of the large mitochondrial respiration complexes
thereby resulting in respiration defects, even when somatic
mutations occur at random sites [23]. This idea could be
examined by complete sequence analysis of mtDNA in tissues of
m/m mice.
Supporting Information
Table S1 Isolation of the trans-mitochondrial cybrids.
aB82 cells are fibrosarcomas derived from the L929 fibroblast cell
line (C3H/An mouse strain), and r0 B82 cells without their own
mtDNA were isolated in our previous report (9). bUP- represent
the selection medium without uridine and pyruvate to exclude
unfused r0 B82 cells.
(DOC)
Table S2 Characterization of the mice used in the
previous studies and this study. a A B6J strain used in this
study corresponds to a B6JJcl strain generated by sibling mating
more than 40 times in CLEA Japan (Jcl). b Expression of a hair
graying phenotype is not detectable in this strain because of its
phenotypic expression of white hair color [6]. c Alopecia was
observed in m/m mice with B6 strain nuclear genome [7] and in
m/m mice with 129R1/B6 strain nuclear genome [6], but not in
m/m mice with B6JJcl nuclear genome generated in this study.
Since nuclear genomes are very close between B6 strain used in
the previous study [7] and B6JJcl strain used in this study,
variability of nuclear genome may not be responsible for the lack
of alopecia in our m/m mice. On the contrary, this study also
showed that m/m mice as well as mito-miceD sharing the same
B6JJcl nuclear genetic background and feeding conditions did not
express alopecia (Fig. 4), suggesting that slight variability of nuclear
genome between B6 and B6JJcl mice and/or different conditions
for feeding and maintenance may due at least in part to the
discrepancy that the alopecia was not observed in m/m mice of
this study.
(DOC)
Table S3 Frequencies of lymphoma in dead or mori-
bund mice. a Individual codes were allocated in order of death.
(DOC)
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